Herein, Nm23/NDPK-A expression was confirmed immunohistochemically, though Okabe-Kado et al reported that the serum Nm23/NDPK-A level may contribute to predicting prognosis of neuroblastoma patients [48]. Here, NME1 is linked to neuroblastoma.